Rite Aid Investors Should Take A Hard Look At The Walgreens Merger Valuation Before Voting

2/27/17

Soon Rite Aid (NYSE:RAD) shareholders will be asked by its board of directors and its senior management (one of whom, Mr. Standley enjoys both positions of Chairman and CEO; separated functions at CVS (NYSE:CVS) and Walgreens (NASDAQ:WBA)) to vote on an amended and significantly lowered merger stock price, as much as a nearly 30% haircut. They will give you all kinds of reasons why they agreed to Walgreens' demands based on its current performance; however, Walgreens' interest in Rite Aid has nothing to do with that or its current mismanagement.

Like they did in 2008 and 2009 when Walgreens purchased all of Rite Aid's stores in Las Vegas and San Francisco, (stores that this writer/shareholder visited as part of a 14-year audit of stores and who was generally displeased in what he viewed) they are attempting to purchase now the future "goldmine profits" performance that likely also happened when they purchased those two locations and removed the mismanagement. They are now attempting to purchase all of Rite Aid "on the cheap" from a senior management whose bags are long packed and ready to go.

READ FULL ARTICLE HERE